← Leaderboards
Venkata Sabbisetti
Brigham And Women'S Hospital
$2,832,886
Attributed
$4,759,179
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,759,179 · 3
By mechanism
U01$2,889,440 · 2
R01$1,869,739 · 1
Top collaborators
- Jennifer A. Lewis4 shared
- Ryuji Morizane4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Sushrut S. Waikar$14,689,878
- Benjamin D Humphreys$13,400,455
- Axel Krieger$3,632,145
- Jessica R. Allegretti$3,079,283
- Craig Robert Brooks$4,066,602
Others in their field
Other Emerging Leaders on “Cell Death”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Barbara Burtness · Yale University$11,235,253
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- William H. Peranteau · Children'S Hosp Of Philadelphia$10,264,302
- Adam David Hoppe · South Dakota State University$9,046,059
- Amit Singal · Ut Southwestern Medical Center$8,676,653
Research focus
Cell DeathEngineeringIn VitroTissuesPharmaceutical PreparationsBaseEffective TherapyExhibitsIn VivoTechnologyTubular FormationToxic EffectSimulationBlood VesselsAdverse EffectsCell LineMechanicsCytokineAnimalsCytokine TherapyBiodistributionCaringBiocompatible MaterialsCritical Pathways
Grant awards (9)
Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editing$713,860
U01 · FY2022 · DK
Spatiotemporal delivery of synergistic drug combinations to kidney cancer$389,939
R01 · FY2022 · CA · contact PI
Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editing$713,860
U01 · FY2021 · DK
Spatiotemporal delivery of synergistic drug combinations to kidney cancer$378,235
R01 · FY2021 · CA · contact PI
Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editing$713,860
U01 · FY2020 · DK
Spatiotemporal delivery of synergistic drug combinations to kidney cancer$378,235
R01 · FY2020 · CA · contact PI
Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editing$747,860
U01 · FY2019 · EB
Spatiotemporal delivery of synergistic drug combinations to kidney cancer$362,400
R01 · FY2019 · CA · contact PI
Spatiotemporal delivery of synergistic drug combinations to kidney cancer$360,930
R01 · FY2018 · CA · contact PI